Small molecules in the treatment of COVID-19
2022 · Signal Transduction and Targeted Therapy · 109 citations
https://doi.org/10.1038/s41392-022-01249-8
K
Ke Men
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
3.4K
Citations
33
h-index
60
i10-index
Ke Men is an academic researcher from Sichuan University. The author has contributed to research in topics: RNA Interference and Gene Delivery & Virus-based gene therapy research & Immunotherapy and Immune Responses. The author has an h-index of 33, co-authored 80 publications.
ORCID: 0000-0002-0587-9961Papers by this author
worksOxidized mitochondrial DNA sensing by STING signaling promotes the antitumor effect of an irradiated immunogenic cancer cell vaccine
2020 · Cellular and Molecular Immunology · 86 citations
https://doi.org/10.1038/s41423-020-0456-1
Time–temperature chromatic sensor based on polydiacetylene (PDA) vesicle and amphiphilic copolymer
2010 · Sensors and Actuators B Chemical · 78 citations
https://doi.org/10.1016/j.snb.2010.06.041
Advances in clinical application of nanoparticle-based therapy for cancer treatment: A systematic review
2024 · Nano TransMed · 64 citations
https://doi.org/10.1016/j.ntm.2024.100036
Chimeric Antigen Receptor-Engineered Cell Membrane-Coated Nanoparticles Promote Dual-Targeted mRNA-Based Cancer Gene Therapy
2025 · ACS Nano · 8 citations
https://doi.org/10.1021/acsnano.4c18153
Bacterial Lysate–Based Bifunctional mRNA Nanoformulation for Efficient Colon Cancer Immunogene Therapy
2024 · ACS Applied Materials & Interfaces · 2 citations
https://doi.org/10.1021/acsami.4c07684
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat